Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- ALL-RISE: AI-Supported Coronary Flow Assessment Performs Similarly to Gold-Standard Wire-Based TestingFFRangio, a minimally invasive, artificial intelligence (AI)-assisted, novel method of measuring fractional flow reserve (FFR), performed similarly to traditional wire-based testing in patients with coronary artery disease (CAD) undergoing assessment for PCI, according to results from the ALL-RISE trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in […]
- CHIP-BCIS3: LV Unloading Not Beneficial During PCI in Patients With Severe LV DysfunctionAmong patients with severe left ventricular (LV) dysfunction and severe coronary heart disease undergoing complex PCI, elective LV unloading with a microaxial flow pump did not reduce the risk of major adverse clinical outcomes and carried a greater risk of all-cause and cardiovascular mortality...
- FAST III: Novel Minimally Invasive vFFR Noninferior to FFR For RevascularizationVessel fractional flow reserve (vFFR)-guided revascularization was noninferior to pressure-wire-based fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary lesions, according to results from the FAST III trial presented during a Late-Breaking Clinical Trials session...
- James T. Dove Keynote Highlights Power of Teams in Delivering the Next Generation of CV CareThe enduring impact of teamwork in cardiovascular medicine took center stage during the James T. Dove Lecture at ACC.26, delivered by ACC Past President Cathleen Biga, MSN, MACC. Drawing on the legacy of James T. Dove, MD, MACC, Biga issued a clear and compelling call to action: the future of high-quality cardiovascular care depends not […]
- ACC.26 Opens With Energy, Purpose and a Call to Lead – TogetherFrom the moment the doors opened, the energy in the room set the tone for a meeting defined by innovation, mentorship and resilience. The session began with a vibrant second line procession ushering in ACC leaders and VIPs, bringing the spirit of the Big Easy directly into the convention hall.